Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study
Tóm tắt
Từ khóa
Tài liệu tham khảo
CF PT, Juhlin E (1963) Demodex folliculorum and blepharitis. Arch Dermatol 88:298–302. https://doi.org/10.1001/archderm.1963.01590210056008
English FP, Nutting WB (1981) Demodicosis of ophthalmic concern. Am J Ophthalmol 91:362–372. https://doi.org/10.1016/0002-9394(81)90291-9
Elston CA, Elston DM (2014) Demodex mites. Clin Dermatol 32:739–743. https://doi.org/10.1016/j.clindermatol.2014.02.012
Nicholls SG, Oakley CL, Tan A, Vote BJ (2017) Demodex species in human ocular disease: new clinicopathological aspects. Int Ophthalmol 37:303–312. https://doi.org/10.1007/s10792-016-0249-9
Ayres BD, Donnenfeld E, Farid M, Gaddie IB, Gupta PK, Holland E, Karpecki PM, Lindstrom R, Nichols KK, Pflugfelder SC, Starr CE, Yeu E (2023) Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH). Eye (Lond). https://doi.org/10.1038/s41433-023-02500-4
Farid M, Ayres BD, Donnenfeld E, Gaddie IB, Gupta PK, Holland E, Lindstrom R, Pflugfelder SC, Karpecki PM, Nichols KK, Starr CE, Yeu E (2023) Delphi panel consensus regarding current clinical practice management options for Demodex blepharitis. Clin Ophthalmol 27(17):667–679. https://doi.org/10.2147/OPTH.S399989
Helm CJ (2022) Treatment of ocular Demodex infestation with topical ivermectin cream. Am J Ophthalmol Case Rep 26:101551. https://doi.org/10.1016/j.ajoc.2022.101551
Choi Y, Eom Y, Yoon EG, Song JS, Kim IH, Kim HM (2022) Efficacy of topical ivermectin 1% in the treatment of Demodex blepharitis. Cornea 41:427–434. https://doi.org/10.1097/ICO.0000000000002802
Gao YY, Di Pascuale MA, Li W, Liu DT, Baradaran-Rafii A, Elizondo A, Kawakita T, Raju VK, Tseng SC (2005) High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci 46:3089–3094. https://doi.org/10.1167/iovs.05-0275
Laing R, Gillan V, Devaney E (2017) Ivermectin - old drug, new tricks? Trends Parasitol 33:463–472. https://doi.org/10.1016/j.pt.2017.02.004
Van Voorhis WC (2015) Profile of William C. Campbell, Satoshi Omura, and Youyou Tu, 2015 Nobel Laureates in physiology or medicine. Proc Natl Acad Sci U S A 112:15773–15776
Cupp EW, Sauerbrey M, Richards F (2010) Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy. Acta Trop. https://doi.org/10.1016/j.actatropica.2010.08.009
Martin RJ, Robertson AP, Choudhary S (2021) Ivermectin: an anthelmintic, an insecticide, and much more. Trends Parasitol 37:48–64. https://doi.org/10.1016/j.pt.2020.10.005
Nabi-Afjadi M, Mohebi F, Zalpoor H, Aziziyan F, Akbari A, Moradi-Sardareh H, Bahreini E, Moeini AM, Effatpanah H (2023) A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective? Inflammopharmacology 31:21–35. https://doi.org/10.1007/s10787-022-01129-1
Kang CN, Shah M, Tan J (2021) Rosacea: an update in diagnosis, classification and management. Skin Therapy Lett 26:1–8
Ebbelaar CCF, Venema AW, Van Dijk MR (2018) Topical ivermectin in the treatment of papulopustular rosacea: a systematic review of evidence and clinical guideline recommendations. Dermatol Ther (Heidelb) 8:379–387. https://doi.org/10.1007/s13555-018-0249-y
Sahni DR, Feldman SR, Taylor SL (2018) Ivermectin 1% (CD5024) for the treatment of rosacea. Expert Opin Pharmacother 19:511–516. https://doi.org/10.1080/14656566.2018.1447562
Kircik LH, Del Rosso JQ, Layton AM, Schauber J (2016) Over 25 Years of Clinical Experience With Ivermectin: An overview of safety for an increasing number of indications. J Drugs Dermatol 15:325–332
Bitton E, Aumond S (2021) Demodex and eye disease: a review. Clin Exp Optom 104:285–294. https://doi.org/10.1111/cxo.13123